Download Citation
Article Source:
Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer
Toren P,
Kim S,
Johnson F,
Zoubeidi A
(2016)
Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer.
PLOS ONE 11(4): e0152861.
https://doi.org/10.1371/journal.pone.0152861